Evidence map›Paper›PMID 33002578›Full record

ArticleBiochimica et biophysica acta. Molecular basis of disease2021

Effect of alanine supplementation on oxalate synthesis.

Kyle D Wood, Brian L Freeman, Mary E Killian, Win Shun Lai, Dean Assimos, John Knight, Sonia Fargue

Open access · greenAbstract read
In one paragraph

Article in Biochimica et biophysica acta. Molecular basis of disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Kyle D WoodUniversity of Alabama at Birmingham, Department of Urology, Birmingham, AL, United States of America.
Brian L FreemanCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, United States of America.
Mary E KillianUniversity of Tennessee Health Science Center, Department of Urology, Memphis, TN, United States of America.
Win Shun LaiUniversity of Texas Medical Branch, Division of Urology, Galveston, TX, United States of America.
Dean AssimosUniversity of Alabama at Birmingham, Department of Urology, Birmingham, AL, United States of America.
John KnightUniversity of Alabama at Birmingham, Department of Urology, Birmingham, AL, United States of America.
Sonia FargueUniversity of Alabama at Birmingham, Department of Urology, Birmingham, AL, United States of America. Electronic address: sfargue@uab.edu.
University of Alabama at Birmingham · USLa Jolla Institute for Immunology · USThe University of Texas Medical Branch at Galveston · USUniversity of Alabama at Birmingham Hospital · USUniversity of Tennessee Health Science Center · US

Funding

Why is the prevalence of obesity so high in U.S. Southern States? Regional predictors of BMI and obesity treatment response.P30DK056336 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI James O Hill · 2000 to 2026
$31.9M
UAB-UCSD O'Brien Core Center for Acute Kidney Injury ResearchP30DK079337 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI AGARWAL, ANUPAM · 2008 to 2022
$18.3M
Oxalobacter formigenes colonization and oxalate excretion in calcium oxalate kidney stone diseaseR01DK087967 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI KNIGHT, JOHN · 2011 to 2020
$3.5M
The Influence of Obesity on Oxalate Metabolism and Handling in Calcium Oxalate Stone FormersP20DK119788 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HOLMES, ROSS P · 2018 to 2021
$1.2M
Obesity and Endogenous Oxalate SynthesisK08DK115833 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WOOD, KYLE D · 2018 to 2022
$960k
GLYCOLATE METABOLISM AND KIDNEY OXALATEK01DK114332 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI FARGUE, SONIA · 2017 to 2021
$883k
NIDDK NIH HHS K01 DK114332NIDDK NIH HHS K08 DK115833NIDDK NIH HHS P20 DK119788NIDDK NIH HHS P30 DK056336NIDDK NIH HHS P30 DK079337NIDDK NIH HHS R01 DK087967
6 · The paper itself

Abstract

The Primary Hyperoxalurias (PH) are rare disorders of metabolism leading to excessive endogenous synthesis of oxalate and recurring calcium oxalate kidney stones. Alanine glyoxylate aminotransferase (AGT), deficient in PH type 1, is a key enzyme in limiting glyoxylate oxidation to oxalate. The affinity of AGT for its co-substrate, alanine, is low suggesting that its metabolic activity could be sub-optimal in vivo. To test this hypothesis, we examined the effect of L-alanine supplementation on oxalate synthesis in cell culture and in mouse models of Primary Hyperoxaluria Type 1 (Agxt KO), Type 2 (Grhpr KO) and in wild-type mice. Our results demonstrated that increasing L-alanine in cells decreased synthesis of oxalate and increased viability of cells expressing GO and AGT when incubated with glycolate. In both wild type and Grhpr KO male and female mice, supplementation with 10% dietary L-alanine significantly decreased urinary oxalate excretion ~30% compared to baseline levels. This study demonstrates that increasing the availability of L-alanine can increase the metabolic efficiency of AGT and reduce oxalate synthesis.

Indexed as

AlanineAlcohol OxidoreductasesAnimalsCHO CellsCricetulusHyperoxaluria, PrimaryMiceMice, KnockoutOxalatesTransaminasesAlanineAlanine-glyoxylate transaminaseAlcohol OxidoreductasesOxalatesTransaminasesAlanineAlanine:glyoxylate aminotransferaseKidney stonesOxalatePrimary hyperoxaluria

Identifiers

PMID33002578
PMCPMC7722081
OpenAlexW3090636909

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.